Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand its reach in B-cell cancers.

Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...

WoFi is an instant, no-frills sonic mangler, which is ridiculously easy to use and yields incredibly dramatic results. It's ...

PLC ("TC BioPharm" or the "Company")  a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the first ...

New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health” ...

The new stadium network will serve as a central hub for an expansion of Wi-Fi 6E across the campus, providing high-speed ...

The global Smart Water Meters Market is anticipated to grow from estimated USD 4.61 billion in 2024 to USD 9.04 billion by 2030, at a CAGR of 11.9% during the forecast period. The rising urban ...

In 2024 Q3, Cloudflare started seeing a rise in hyper-volumetric network layer DDoS attacks. In 2024 Q4, the amount of ...